Update: 29.10.2024
Last week: 42 week 2024 (14.10.2024 - 20.10.2024)
Last full month: September 2024
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | |||||||||
| WoW | 10 775 | 1.4% | 13.5% | -0.5 | 18 527 333 | 7.5% | 8.9% | 0.2 | 5.0% |
| MoM | 36 980 | 4.9% | 13.4% | -0.1 | 67 216 861 | 2.1% | 9.2% | -0.3 | 5.8% |
| YTD | 322 382 | 23.5% | 12.0% | 3.2 | 658 973 544 | 34.1% | 9.4% | 1.9 | -9.1% |
| MAT | 402 244 | 25.1% | 11.6% | 2.8 | 824 372 018 | 37.4% | 9.2% | 1.8 | -4.6% |
| BRAINMAX | |||||||||
| WoW | 2 705 | 5.6% | 100.0% | 0 | 8 943 968 | 1.7% | 100.0% | 0 | 5.6% |
| MoM | 7 570 | 10.4% | 100.0% | 0 | 26 517 643 | 8.2% | 100.0% | 0 | 10.4% |
| YTD | 56 966 | 66.6% | 100.0% | 0 | 199 909 370 | 71.2% | 100.0% | 0 | 66.6% |
| MAT | 69 423 | 72.6% | 100.0% | 0 | 244 147 971 | 79.4% | 100.0% | 0 | 72.6% |
| GOLDLINE PLUS | |||||||||
| WoW | 15 507 | 6.9% | 45.6% | -0.2 | 47 640 046 | 5.6% | 37.3% | -0.1 | 7.4% |
| MoM | 61 246 | -7.0% | 45.9% | 0.3 | 190 178 090 | -6.9% | 37.7% | 0.1 | -7.6% |
| YTD | 686 237 | -4.9% | 45.1% | 0.4 | 2 154 864 170 | -3.0% | 36.9% | -2.8 | -5.8% |
| MAT | 833 538 | -2.0% | 45.3% | 0.5 | 2 625 428 495 | 1.2% | 37.4% | -2.5 | -2.9% |
| MIGRENIUM | |||||||||
| WoW | 9 340 | 4.9% | 0.4% | 0 | 3 184 090 | 5.0% | 0.5% | 0 | 1.7% |
| MoM | 41 151 | -21.4% | 0.4% | -0.1 | 13 849 561 | -20.6% | 0.6% | -0.1 | -2.8% |
| YTD | 477 213 | -10.6% | 0.5% | -0.1 | 150 420 917 | 52.1% | 0.7% | 0.2 | 6.5% |
| MAT | 585 038 | -10.9% | 0.5% | -0.1 | 174 168 658 | 44.1% | 0.6% | 0.1 | 9.7% |
| MODELAX-N | |||||||||
| WoW | 27 363 | 5.9% | 19.9% | 0.5 | 13 011 982 | 5.7% | 13.1% | 0.3 | 3.1% |
| MoM | 107 577 | 0.1% | 20.6% | 1.1 | 50 949 280 | 1.1% | 13.5% | 0.7 | -5.3% |
| YTD | 1 189 870 | 29.2% | 22.3% | 3.5 | 522 991 638 | 78.1% | 14.4% | 4 | 8.9% |
| MAT | 1 436 734 | 36.4% | 21.4% | 3.7 | 612 196 951 | 81.0% | 13.6% | 3.6 | 12.8% |
| REDUXIN | |||||||||
| WoW | 11 214 | 8.4% | 33.0% | 0.3 | 56 775 410 | 4.9% | 44.5% | -0.4 | 7.4% |
| MoM | 42 769 | -9.5% | 32.1% | -0.7 | 220 075 387 | -8.9% | 43.7% | -0.8 | -7.6% |
| YTD | 498 950 | -7.2% | 32.8% | -0.5 | 2 649 500 233 | 11.9% | 45.4% | 3.1 | -5.8% |
| MAT | 599 001 | -5.1% | 32.5% | -0.7 | 3 153 912 864 | 15.2% | 44.9% | 2.8 | -2.9% |
| REDUXIN FORTE | |||||||||
| WoW | 3 435 | 13.1% | 10.1% | 0.5 | 14 425 222 | 12.3% | 11.3% | 0.6 | 7.4% |
| MoM | 13 776 | -1.3% | 10.3% | 0.7 | 58 932 380 | 0.6% | 11.7% | 0.9 | -7.6% |
| YTD | 137 967 | 1.3% | 9.1% | 0.6 | 593 951 338 | 12.5% | 10.2% | 0.7 | -5.8% |
| MAT | 167 821 | 5.3% | 9.1% | 0.7 | 719 544 195 | 16.7% | 10.2% | 0.8 | -2.9% |
| SALVISAR | |||||||||
| WoW | 13 631 | 8.8% | 1.7% | 0.1 | 6 003 289 | 9.9% | 1.5% | 0.1 | 2.1% |
| MoM | 47 722 | 21.0% | 1.5% | 0.3 | 20 388 247 | 20.6% | 1.3% | 0.2 | -2.4% |
| YTD | 429 095 | 6.2% | 1.4% | 0.1 | 177 182 947 | 33.4% | 1.2% | 0.2 | -2.5% |
| MAT | 523 290 | -3.3% | 1.3% | -0.1 | 208 158 379 | 15.3% | 1.2% | 0 | 1.0% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 322 382 | 23.5% | 12.0% | 3.2 | 658 973 544 | 34.1% | 9.4% | 1.9 | -9.1% |
| BRAINMAX | 56 966 | 66.6% | 100.0% | 0 | 199 909 370 | 71.2% | 100.0% | 0 | 66.6% |
| GOLDLINE PLUS | 686 237 | -4.9% | 45.1% | 0.4 | 2 154 864 170 | -3.0% | 36.9% | -2.8 | -5.8% |
| MIGRENIUM | 477 213 | -10.6% | 0.5% | -0.1 | 150 420 917 | 52.1% | 0.7% | 0.2 | 6.5% |
| MODELAX-N | 1 189 870 | 29.2% | 22.3% | 3.5 | 522 991 638 | 78.1% | 14.4% | 4 | 8.9% |
| REDUXIN CAPS | 498 950 | -7.2% | 32.8% | -0.5 | 2 649 500 233 | 11.9% | 45.4% | 3.1 | -5.8% |
| REDUXIN FORTE | 137 967 | 1.3% | 9.1% | 0.6 | 593 951 338 | 12.5% | 10.2% | 0.7 | -5.8% |
| SALVISAR | 429 095 | 6.2% | 1.4% | 0.1 | 177 182 947 | 33.4% | 1.2% | 0.2 | -2.5% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 402 244 | 25.1% | 11.6% | 2.8 | 824 372 018 | 37.4% | 9.2% | 1.8 | -4.6% |
| BRAINMAX | 69 423 | 72.6% | 100.0% | 0 | 244 147 971 | 79.4% | 100.0% | 0 | 72.6% |
| GOLDLINE PLUS | 833 538 | -2.0% | 45.3% | 0.5 | 2 625 428 495 | 1.2% | 37.4% | -2.5 | -2.9% |
| MIGRENIUM | 585 038 | -10.9% | 0.5% | -0.1 | 174 168 658 | 44.1% | 0.6% | 0.1 | 9.7% |
| MODELAX-N | 1 436 734 | 36.4% | 21.4% | 3.7 | 612 196 951 | 81.0% | 13.6% | 3.6 | 12.8% |
| REDUXIN CAPS | 599 001 | -5.1% | 32.5% | -0.7 | 3 153 912 864 | 15.2% | 44.9% | 2.8 | -2.9% |
| REDUXIN FORTE | 167 821 | 5.3% | 9.1% | 0.7 | 719 544 195 | 16.7% | 10.2% | 0.8 | -2.9% |
| SALVISAR | 523 290 | -3.3% | 1.3% | -0.1 | 208 158 379 | 15.3% | 1.2% | 0 | 1.0% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 10 775 | 1.4% | 13.5% | -0.5 | 18 527 333 | 7.5% | 8.9% | 0.2 | 5.0% |
| BRAINMAX | 2 705 | 5.6% | 100.0% | 0 | 8 943 968 | 1.7% | 100.0% | 0 | 5.6% |
| GOLDLINE PLUS | 15 507 | 6.9% | 45.6% | -0.2 | 47 640 046 | 5.6% | 37.3% | -0.1 | 7.4% |
| MIGRENIUM | 9 340 | 4.9% | 0.4% | 0 | 3 184 090 | 5.0% | 0.5% | 0 | 1.7% |
| MODELAX-N | 27 363 | 5.9% | 19.9% | 0.5 | 13 011 982 | 5.7% | 13.1% | 0.3 | 3.1% |
| REDUXIN CAPS | 11 214 | 8.4% | 33.0% | 0.3 | 56 775 410 | 4.9% | 44.5% | -0.4 | 7.4% |
| REDUXIN FORTE | 3 435 | 13.1% | 10.1% | 0.5 | 14 425 222 | 12.3% | 11.3% | 0.6 | 7.4% |
| SALVISAR | 13 631 | 8.8% | 1.7% | 0.1 | 6 003 289 | 9.9% | 1.5% | 0.1 | 2.1% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 36 980 | 4.9% | 13.4% | -0.1 | 67 216 861 | 2.1% | 9.2% | -0.3 | 5.8% |
| BRAINMAX | 7 570 | 10.4% | 100.0% | 0 | 26 517 643 | 8.2% | 100.0% | 0 | 10.4% |
| GOLDLINE PLUS | 61 246 | -7.0% | 45.9% | 0.3 | 190 178 090 | -6.9% | 37.7% | 0.1 | -7.6% |
| MIGRENIUM | 41 151 | -21.4% | 0.4% | -0.1 | 13 849 561 | -20.6% | 0.6% | -0.1 | -2.8% |
| MODELAX-N | 107 577 | 0.1% | 20.6% | 1.1 | 50 949 280 | 1.1% | 13.5% | 0.7 | -5.3% |
| REDUXIN CAPS | 42 769 | -9.5% | 32.1% | -0.7 | 220 075 387 | -8.9% | 43.7% | -0.8 | -7.6% |
| REDUXIN FORTE | 13 776 | -1.3% | 10.3% | 0.7 | 58 932 380 | 0.6% | 11.7% | 0.9 | -7.6% |
| SALVISAR | 47 722 | 21.0% | 1.5% | 0.3 | 20 388 247 | 20.6% | 1.3% | 0.2 | -2.4% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #90"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #10"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #30"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #60"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #90"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #20"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
*****
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #20"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs